Project Grant R21AR082999
Award Date
9/23/23
Completion Date
8/31/25
Dollars Obligated
$401K
Awardee
Cleveland Clinic Lerner College Of Medicine Of Case Western Reserve University (M5QFLTCTSQN6)
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44195, USA
Similar Awards
This federal Project Grant award of $147,400.00 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant will fund research at Yale University to investigate how antigen non-related CD4+ T lymphocytes contribute to the pathogenesis of skin fibrosis in systemic sclerosis (scleroderma) and graft-versus-host disease. The research aims to characterize bystander...
This $173,719 federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will fund research conducted by Trustees of Boston University's Medical Campus to assess the use of Spatial Frequency Domain Imaging (SFDI) as an objective measure of skin changes in patients with systemic sclerosis (scleroderma). The research aims to prospectively evaluate SFDI's...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports the development of a novel peptide-based therapeutic agent called M10 for treating skin fibrosis associated with systemic sclerosis (scleroderma). The $613,036 award to Fibrobiologics LLC, a for-profit biotechnology research firm, will fund preclinical studies to determine the...
This federal Project Grant award, valued at $242,310.00, was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports research at Rockefeller University to investigate the long-term impacts of allergic "type 2" skin inflammation on epithelial stem cells, which play a key role in tissue repair and adaptation. Specifically, the research aims to...
This $198,782 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will enable Duke University to develop genetically modified 3D human reconstructed epidermis (RHE) models. The goal is to investigate interactions between the skin microbiome and skin cell populations, including keratinocytes and fibroblasts, using CRISPR/Cas9 knockouts of key skin...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) provides $112,798 to The Leland Stanford Junior University to characterize the role of glucose-binding proteins, specifically DDX50 and NSUN2, in regulating epidermal differentiation and homeostasis. The research aims to define the mechanism by which glucose regulates these RNA-binding proteins to control skin cell...
This $306,324 federal Project Grant award was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant was awarded to the Oklahoma Medical Research Foundation (OMRF) to support a research project titled "Deciphering the Myofibroblast Life Cycle in Skin Wound Healing". The project aims to create a molecular map of the myofibroblast life cycle and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $970,480.00 to the Benaroya Research Institute at Virginia Mason to conduct research focused on understanding the role of T cells in regulating fibroblast gene programs and dysfunction in systemic sclerosis (scleroderma). The project aims to use single-cell spatial transcriptomics and innovative organotypic skin...
This federal Project Grant award, valued at $176,148 and funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support a 5-year research and career development plan for Dr. Maxime Kinet at the University of California, San Francisco (UCSF). The overarching goal is to help Dr. Kinet transition to an independently funded physician-scientist studying the role of...
The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $163,514 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to Brigham & Women's Hospital Inc. in Boston, MA. The grant, awarded on July 1, 2024, supports research to biochemically define a new G protein-coupled receptor (GPCR) signaling pathway with relevance to chemokine signaling and T cell function. The principal investigator, with mentorship...